{
    "id": 19819,
    "fullName": "PIK3CD positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CD positive indicates the presence of the PIK3CD gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5293,
        "geneSymbol": "PIK3CD",
        "terms": [
            "PIK3CD",
            "APDS",
            "IMD14",
            "p110D",
            "P110DELTA",
            "PI3K"
        ]
    },
    "variant": "positive",
    "createDate": "03/15/2016",
    "updateDate": "08/29/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8364,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Zydelig (idelalisib) inhibited PI3K/Akt pathway activation, and resulted in growth inhibition in both patient-derived and established mantle cell lymphoma cell lines in culture (PMID: 27342398).",
            "molecularProfile": {
                "id": 20237,
                "profileName": "PIK3CD positive"
            },
            "therapy": {
                "id": 1023,
                "therapyName": "Idelalisib",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6635,
                    "pubMedId": 27342398,
                    "title": "Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27342398"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20614,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IOA-244 treatment inhibited growth of breast cancer cells expressing PIK3CD in a mouse model (Annals of Oncology, Vol. 30, suppl. 7, 2019, Abs nr: 93P).",
            "molecularProfile": {
                "id": 20237,
                "profileName": "PIK3CD positive"
            },
            "therapy": {
                "id": 9409,
                "therapyName": "IOA-244",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17964,
                    "pubMedId": null,
                    "title": "Preclinical development of a novel, highly selective PI3Kdelta inhibitor, IOA-244, for the treatment of solid malignancies",
                    "url": "https://www.sciencedirect.com/science/article/pii/S0923753419619915"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5076,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY294002 inhibited proliferation and induced apoptosis in acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5078,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rapamune (sirolimus) moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5077,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IC87114 moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 3504,
                "therapyName": "IC87114",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5075,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PI-103 inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 870,
                "therapyName": "PI-103",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5074,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TGX-155 moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 3503,
                "therapyName": "TGX-155",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20237,
            "profileName": "PIK3CD positive",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 20238,
            "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}